Axcan Pharma's $275 million eight-year notes to come via Banc of America

By Paul A. Harris

St. Louis, Jan. 24 - Atom Intermediate Holdings, a financing subsidiary of Axcan Pharma Inc., plans to place $275 million of eight-year senior unsecured notes (B-) via Banc of America Securities LLC, according to Isabelle Adjahi, Axcan's director of investor relations.

She added that the deal is expected to come to market in the next few weeks.

The bonds are part of the financing for the buyout of Axcan by TPG Capital. That financing also includes $475 million of senior secured credit facilities.

Axcan is a Mont-Saint-Hilaire, Quebec-based specialty pharmaceutical company focused on gastroenterology, with operations in North America and Europe.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.